Wednesday, 13 October 2010

Stopping natalizumab causes inflammatory rebound in MS

From the MSRC:

Some multiple sclerosis (MS) patients who discontinue natalizumab therapy may experience a rebound of disease activity, according to research published online Oct. 11 in the Archives of Neurology.  For more click here.